Last updated: 16 February 2024 at 12:28pm EST

Jennifer Marlowe Net Worth




The estimated Net Worth of Jennifer Marlowe is at least $89 Tysiąc dollars as of 2 December 2023. Jennifer Marlowe owns over 11,888 units of Solid Biosciences Inc stock worth over $89,041 and over the last 2 years Jennifer sold SLDB stock worth over $0.

Jennifer Marlowe SLDB stock SEC Form 4 insiders trading

Jennifer has made over 1 trades of the Solid Biosciences Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Jennifer exercised 11,888 units of SLDB stock worth $89,041 on 2 December 2023.

The largest trade Jennifer's ever made was exercising 11,888 units of Solid Biosciences Inc stock on 2 December 2023 worth over $89,041. On average, Jennifer trades about 3,963 units every 0 days since 2022. As of 2 December 2023 Jennifer still owns at least 11,888 units of Solid Biosciences Inc stock.

You can see the complete history of Jennifer Marlowe stock trades at the bottom of the page.



What's Jennifer Marlowe's mailing address?

Jennifer's mailing address filed with the SEC is C/O SOLID BIOSCIENCES INC., 500 RUTHERFORD AVENUE, THIRD FLOOR, CHARLESTOWN, MA, 02129.

Insiders trading at Solid Biosciences Inc

Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ... oraz Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.



What does Solid Biosciences Inc do?

solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.



Complete history of Jennifer Marlowe stock trades at Solid Biosciences Inc

Osoba
Trans.
Transakcja
Łączna cena
Jennifer Marlowe
CSO
Opcja Ćwiczenie $35,783
2 Dec 2023


Solid Biosciences Inc executives and stock owners

Solid Biosciences Inc executives and other stock owners filed with the SEC include: